Product image of Mibac (Clindamycin, Benzoyl Peroxide) supplied by GNH India

Mibac

Active Ingredient:
Clindamycin, Benzoyl Peroxide
Origin:
EU

Mibac (Clindamycin, Benzoyl Peroxide)

Clindamycin, the active ingredient in Mibac, is an antibiotic and keratolytic combination presented as a topical formulation for skin use. It treats acne vulgaris in adolescents and adults by reducing bacterial growth and promoting exfoliation of clogged pores. The formulation combines clindamycin with benzoyl peroxide, providing both antibacterial and keratolytic actions that help clear existing lesions and prevent new ones.

GNH India supplies Mibac as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance.

Manufacturer / TM Owner

Mibe Pharma España S.L.U.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mibac is used in the treatment of acne, targeting the bacterial and keratinocyte processes that contribute to lesion formation.

  • Acne vulgaris: reduces inflammatory lesions and comedones, improving skin appearance.
  • Mild to moderate acne: decreases papules and pustules while preventing new lesion development.
  • Post‑acne maintenance: helps maintain clear skin after initial therapy by limiting bacterial regrowth.

How It Works

  • Mibac combines clindamycin, a lincosamide antibiotic that binds to the 50S ribosomal subunit of susceptible bacteria and inhibits protein synthesis, with benzoyl peroxide, which decomposes on the skin to release oxygen free radicals that exert bactericidal activity and promote keratolysis. The dual action reduces Cutibacterium acnes colonisation and unclogs pores, addressing two key pathogenic factors in acne.

Side Effects

Topical application of Mibac may be associated with local skin reactions.

Common Side Effects

  • Irritation: mild redness or stinging at the application site.
  • Dryness: peeling or flaking of the treated skin.
  • Itching: transient pruritus after use.
  • Burning sensation: temporary warmth or burning feeling.

Serious or Rare Side Effects

  • Allergic contact dermatitis: severe rash, swelling, or blistering.
  • Photosensitivity: increased sensitivity to sunlight causing burns.
  • Severe skin ulceration: deep sores or necrosis at the application site.

Precautions & Warnings

When using Mibac, certain precautions should be observed to minimise risk and ensure effective therapy.

  • Avoid excessive use: apply only as directed to prevent skin irritation.
  • Do not combine with other topical acne products containing retinoids or salicylic acid unless advised.
  • Discontinue if severe irritation occurs: seek medical advice.
  • Use sunscreen: benzoyl peroxide can increase photosensitivity.
  • Pregnancy and lactation: consult healthcare professional before use.
  • Store at room temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Mibac may interact with certain topical or systemic agents; awareness of these interactions helps avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

  • Concurrent use with oral antibiotics that share similar resistance profiles may diminish clindamycin effectiveness.
  • Combining with other potent keratolytic agents (e.g., high‑strength salicylic acid) can cause severe skin irritation.
  • Use with systemic retinoids may increase risk of skin dryness and irritation.

Moderate Interactions (Monitor Closely)

  • Application with other topical antibiotics may increase risk of bacterial resistance.
  • Use with skin lightening agents may alter drug absorption.
  • Concurrent use of photosensitizing drugs (e.g., tetracyclines) may enhance photosensitivity.

Frequently Asked Questions

Mibac is a topical medication indicated for the treatment of acne vulgaris. It combines an antibiotic with a keratolytic agent to reduce bacterial colonisation, clear existing lesions, and prevent the formation of new acne lesions on the skin.

Clindamycin, one of the active ingredients in Mibac, inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit of susceptible skin bacteria, particularly Cutibacterium acnes, thereby reducing bacterial growth and inflammation associated with acne.

The dosage of Mibac is determined by the prescribing healthcare professional based on the severity of acne and individual patient factors. The prescriber will specify the amount to apply, frequency, and duration of treatment.

Safety data for Mibac in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To order Mibac, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Mibac offers a dual mechanism by pairing clindamycin, an antibiotic, with benzoyl peroxide, a keratolytic and antibacterial agent. This combination can be more effective than single‑agent therapies, such as monotherapy with a topical antibiotic or benzoyl peroxide alone, especially for patients with resistant or moderate acne.

Mibac should be stored at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight, and avoid freezing. Follow any additional handling instructions provided on the label.

Mibac is applied topically to clean, dry skin. A thin layer is spread over the affected areas, usually once or twice daily as directed by a healthcare professional. Hands should be washed after application, and the product should not be applied to broken or irritated skin.

Serious but rare risks include allergic contact dermatitis, severe skin ulceration, and photosensitivity reactions that can lead to sunburn. If any signs of a severe rash, swelling, blistering, or unexpected skin damage occur, discontinue use and seek medical attention promptly.

Mibac should be avoided by individuals with a known hypersensitivity to clindamycin, benzoyl peroxide, or any other component of the formulation. It is also contraindicated on severely damaged or inflamed skin and should be used with caution in patients with a history of photosensitivity.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Clindamycin, Benzoyl Peroxide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT